Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Bone Biologics Corp (BBLG)

Bone Biologics postpones 2026 annual meeting to September 28, 2026

Neutral Impact 2 of 5 shareholder Written later

Bone Biologics' board voted on July 15, 2026 to postpone the annual stockholder meeting from August 11 to September 28, 2026, so an additional proposal can be included in the proxy statement and stockholders have more time to review it. The company also moved the record date to August 6, 2026 and the deadline for director nominations and other proposals to July 26, 2026. The change is administrative and does not state any financial results.

Key points

  • Annual meeting moved from August 11, 2026 to September 28, 2026, at 11:30 a.m. Eastern Time in Burlington, Massachusetts
  • New record date set for August 6, 2026
  • Stockholder deadline for director nominees or proposals is now July 26, 2026
  • Company plans to file a Definitive Proxy Statement on Schedule 14A with an additional stockholder proposal

The filing

CompanyBone Biologics Corp (BBLG)
Form8-K, current report
Filed with the SECJul 16, 2026, 5:25 PM ET
Accession number0001493152-26-033586

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.